Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6251–6300 of 33088
Tuomo Pätsi, Thomas I. H. Dubin, Peter Feinberg, Michele Galen, Thomas Graney and Michael Rice tendered their resignations as members of the Company’s and its subsidiaries’ Boards of Directors, which resignations were effective on October 13, 2024 as of immediately following the filing of the Petitions.
The Company also terminated Scott A. McPherson, the Company’s Chief Financial Officer, and Joseph Wagner, the Company’s Chief Scientific Officer, each effective October 8, 2024, and the Company’s Chief Restructuring Officer and Interim Chief Executive Officer, Kaile A. Zagger, was also terminated from such positions and became an advisor to the Company effective as of October 8, 2024.
accepted the resignation of Li Gong from her position as Chief Operations Officer.
accepted the resignation of Ying Liu from her position as Chairwoman and a director of the Board.
accepted the resignation of Chen Sung from his position as a director of the Board.
Effective October 21, 2024, Franz W. Cerwinka will cease to serve as Xylem Inc.’s (the “Company”) Senior Vice President and President, Applied Water and Xylem Business Transformation.
Mario Longhi will cease serving as Interim President and Chief Executive Officer, effective November 1, 2024.
Alan Harris will cease serving as the Board’s Presiding Director, effective November 1, 2024.
On October 1, 2024, Stewart Fisher, Ph.D. informed us of his intent to retire from the role of Chief Scientific Officer of C4 Therapeutics, Inc.
On October 8, 2024, the Board of Directors (the "Board") of The Beauty Health Company (the "Company") terminated Daniel Watson's employment as Chief Revenue Officer of the Company without cause, effective as of October 14, 2024.
On October 13, 2024, J. Stephan Dolezalek notified Benson Hill, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”), effective as of such date.
On October 11, 2024, Robert C. Flexon, a member of the boards of directors (the “Boards”) of PG&E Corporation and Pacific Gas and Electric Company (the “Utility”) and Chair of the Board of PG&E Corporation, notified PG&E Corporation and the Utility of his decision to resign from the Boards, effective October 31, 2024.
Sabra Purtill will continue to serve as Executive Vice President and Chief Financial Officer until such date.
Effective August 31, 2024, Thomas L. Kleinhardt and Gregory V. Varner retired as directors of Isabella Bank Corporation (the “Corporation”) and its subsidiary, Isabella Bank, after reaching the mandatory age for retirement according to the Corporation’s bylaws.
Effective August 31, 2024, Thomas L. Kleinhardt and Gregory V. Varner retired as directors of Isabella Bank Corporation (the “Corporation”) and its subsidiary, Isabella Bank, after reaching the mandatory age for retirement according to the Corporation’s bylaws.
Effective October 10, 2024, Dycom Industries, Inc. (the “Company”) and Jason T. Lawson, Vice President and Chief Human Resources Officer, agreed that Mr. Lawson would cease to be employed by the Company and that such separation was an involuntary termination without cause pursuant to the terms of his employment agreement with the Company.
On October 9, 2024, Henry G. Kleemeier, age 80, notified Excelerate Energy, Inc. (the “Company”) of his decision to retire as a member of the Board of Directors of the Company (the “Board”), effective immediately.
On October 7, 2024, Christopher Savoie resigned as President and Chief Executive Officer of the Company, as well as a member of the board of directors of the Company, in each case effective immediately.
On October 7, 2024, Christopher Savoie resigned as President and Chief Executive Officer of the Company, as well as a member of the board of directors of the Company, in each case effective immediately.
Effective October 9, 2024, the Company determined that Yudong Cao, the Company’s Chief Technology Officer, will serve in that role until October 16, 2024, following which he will continue to assist the Company on a part-time basis, as needed.
As of October 11, 2024, Steven S. Reed, the Chief Legal Officer and Corporate Secretary of BrightSpring Health Services, Inc. (the “Company”), has made the decision to retire from his position after over twenty years of service with the Company, first as a director, and the final eleven years as Chief Legal Officer.
Additionally, effective immediately following and contingent upon the Closing, J. Bryant Kirkland III resigned from his position as President of the Company
Effective immediately following and contingent upon the closing (the “Closing”) of the transactions contemplated by the Agreement and Plan of Merger (the “Merger Agreement”), dated as of August 21, 2024, by and among Vector Group Ltd., JTI (US) Holding Inc., a Delaware corporation (“JTI US”) and Vapor Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of JTI US, J. Bryant Kirkland III resigned from his position as a member of the Board and all committees thereof.
Deborah Fasanelli resigned from her position as Secretary and Treasurer of the Company.
Rance Long, Senior Vice President, Sales & Marketing, will retire from MRC Global Inc. (the “Company”) on or about May 2, 2025
On October 7, 2024, Ekta Singh-Bushell notified Cisco Systems, Inc. (“Cisco”) of her decision not to stand for re-election at Cisco’s 2024 annual meeting of stockholders (the “2024 Annual Meeting”).
On October 3, 2023, Hon Man Yun passed away, thereby concluding his position as Chief Executive Officer of Wave Sync Corp.
On October 10, 2024, William B. Miller resigned from his position as Chief Financial Officer (and principal financial and accounting officer) of reAlpha Tech Corp. (the “Company”) and its subsidiaries, effective immediately.
The appointment follows the resignation of Sherri Luther on October 10, 2024, from her position as Chief Financial Officer, effective immediately.
On October 7, 2024, Stephen Willard, the Chief Executive Officer of NRx Pharmaceuticals, Inc. (the “ Company ”) provided notice to the Board that he was resigning from the Company, effective immediately
Mark Matheos, Chief Financial Officer of Appian Corporation (the “Company”) notified the Company that he will be leaving the Company effective November 8, 2024, to pursue an opportunity as a CFO at another company.
As previously disclosed, Michael J. Sofia announced his retirement as Chief Scientific Officer of Arbutus Biopharma, Inc. (the “Company”), a subsidiary of Arbutus Biopharma Corporation, effective December 31, 2024.
In connection with the consummation of the Merger, each of Steve Hislop, Jody Bilney, Randall DeWitt, Nancy Freda-Smith, Jon Howie, Saed Mohseni and Ira Zecher, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time, and Anthony G. Morrow, the sole director of Merger Sub immediately prior to the Effective Time, became the sole director of the Company as of the Effective Time.
In connection with the consummation of the Merger, each of Steve Hislop, Jody Bilney, Randall DeWitt, Nancy Freda-Smith, Jon Howie, Saed Mohseni and Ira Zecher, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time, and Anthony G. Morrow, the sole director of Merger Sub immediately prior to the Effective Time, became the sole director of the Company as of the Effective Time.
In connection with the consummation of the Merger, each of Steve Hislop, Jody Bilney, Randall DeWitt, Nancy Freda-Smith, Jon Howie, Saed Mohseni and Ira Zecher, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time, and Anthony G. Morrow, the sole director of Merger Sub immediately prior to the Effective Time, became the sole director of the Company as of the Effective Time.
In connection with the consummation of the Merger, each of Steve Hislop, Jody Bilney, Randall DeWitt, Nancy Freda-Smith, Jon Howie, Saed Mohseni and Ira Zecher, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time, and Anthony G. Morrow, the sole director of Merger Sub immediately prior to the Effective Time, became the sole director of the Company as of the Effective Time.
In connection with the consummation of the Merger, each of Steve Hislop, Jody Bilney, Randall DeWitt, Nancy Freda-Smith, Jon Howie, Saed Mohseni and Ira Zecher, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time, and Anthony G. Morrow, the sole director of Merger Sub immediately prior to the Effective Time, became the sole director of the Company as of the Effective Time.
In connection with the consummation of the Merger, each of Steve Hislop, Jody Bilney, Randall DeWitt, Nancy Freda-Smith, Jon Howie, Saed Mohseni and Ira Zecher, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time, and Anthony G. Morrow, the sole director of Merger Sub immediately prior to the Effective Time, became the sole director of the Company as of the Effective Time.
In connection with the consummation of the Merger, each of Steve Hislop, Jody Bilney, Randall DeWitt, Nancy Freda-Smith, Jon Howie, Saed Mohseni and Ira Zecher, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time, and Anthony G. Morrow, the sole director of Merger Sub immediately prior to the Effective Time, became the sole director of the Company as of the Effective Time.
Robert G. Lucian, Senior Vice President and Chief Financial Officer, informed La-Z-Boy Incorporated (the “Company”) of his planned retirement from the Company at the end of the fiscal year, effective April 26, 2025.
Douglas E. Jones, Neogen’s Chief Operating Officer, has communicated his intent to retire in early 2025.
On October 7, 2024, Mr. Stephen Kok Koon Tan resigned as CEO and director of Summit Networks Inc. (the “Company”).
On October 7, 2024, Mr. Stephen Kok Koon Tan resigned as CEO and director of Summit Networks Inc. (the “Company”).
On October 9, 2024, Anelise Sacks notified Analog Devices, Inc. (the “Company”) of her decision to resign as Executive Vice President and Chief Customer Officer of the Company to explore other opportunities, effective as of March 31, 2025, or such earlier date as the Company appoints a new Chief Customer Officer.
Christopher L. Mapes, Executive Chair of the Board of Directors of the Company (the “Board”), will retire from his position as Executive Chair and a member of the Board on December 31, 2024.
On October 8, 2024, Wynne Comer resigned from her position as the interim Chief Financial Officer of AGL Private Credit Income Fund (the “Company”), effective on such date.
On October 4, 2024, Craig Foster notified PodcastOne, Inc. (the “Company”) that he was resigning from service on the Company’s board of directors (the “Board”), effective as of the same date, to pursue other current professional obligations.
On October 4, 2024, Craig Foster notified LiveOne, Inc. (the “Company”) that he was resigning from service on the Company’s board of directors (the “Board”), effective as of the same date, to pursue other current professional obligations.
On October 9, 2024, Mr. Aaron Weaver, a member of the Board of Directors of Bionomics Limited (the “Company”), provided the Company’s board with notice that he was resigning from the Board of Directors, effective October 9, 2024.
Mr. R. Brice Dille has been relieved of his position as Interim Chief Financial Officer (principal financial officer and principal accounting officer) effective October 9, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.